CORD-19:8c51cf0cc444f6a851ad178040369984759ddfec / 5523-5673
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/8c51cf0cc444f6a851ad178040369984759ddfec","sourcedb":"CORD-19","sourceid":"8c51cf0cc444f6a851ad178040369984759ddfec","text":"Clearly, additional studies are needed to carefully evaluate fluctuations of the antibody titer during the course of the disease and during treatment.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T48","span":{"begin":0,"end":150},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"TextSentencer_T48","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T24","span":{"begin":0,"end":150},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T24","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T48","span":{"begin":0,"end":150},"obj":"Sentence"}],"attributes":[{"subj":"T48","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#a5ec93","default":true},{"id":"Epistemic_Statements","color":"#ec93bf"},{"id":"CORD-19_Custom_license_subset","color":"#93d9ec"}]}]}}